A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...
MedPage Today on MSN3d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss DrugsSAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.
It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...
Ministers have been urged to ditch "gimmicks and soundbites" while addressing the soaring cost of obesity to the NHS.
Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Semaglutide, the active ingredient doing all the work ... but it’s not the most budget-friendly—there’s a membership fee on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback